Solid Biosciences Inc. (SLDB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Solid Biosciences Inc.

    NASDAQ: SLDB · Real-Time Price · USD
    5.98
    0.06 (1.01%)
    At close: Sep 26, 2025, 1:14 PM

    Solid Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 8.09M 13.62M
    Cost of Revenue
    		 2.46M 2.58M 2.41M 2.96M
    Gross Profit
    		 -2.46M -2.58M 5.69M 10.66M
    Operating Income
    		 -129.73M -104.31M -106.45M -72.25M
    Interest Income
    		 9.47M 7.14M 2.62M 64K
    Pretax Income
    		 -124.7M -96.02M -85.98M -72.19M
    Net Income
    		 -124.7M -96.02M -85.98M -72.19M
    Selling & General & Admin
    		 33.3M 27.75M 21.67M 27.14M
    Research & Development
    		 96.43M 76.56M 78.42M 58.74M
    Other Expenses
    		 -2.46M -2.58M -63.96M -2.96M
    Operating Expenses
    		 127.27M 101.73M 36.13M 82.91M
    Interest Expense
    		 340K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 129.73M 104.31M 114.55M 85.87M
    Income Tax Expense
    		 n/a n/a -20.47M -64K
    Shares Outstanding (Basic)
    		 40.82M 19.88M 8.51M 7.12M
    Shares Outstanding (Diluted)
    		 40.82M 19.88M 8.51M 7.12M
    EPS (Basic)
    		 -3.06 -4.83 -10.1 -10.13
    EPS (Diluted)
    		 -3.06 -4.83 -10.1 -10.13
    EBITDA
    		 -121.9M -93.43M -96.87M -69.29M
    EBIT
    		 -124.36M -96.02M -99.27M -72.25M
    Depreciation & Amortization
    		 2.46M 2.58M 2.41M 2.96M

    Add to Watchlist